share_log

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

Novavax | 4: Statement of changes in beneficial ownership of securities-Director Rodgers Richard J

诺瓦瓦克斯医药 | 4:持股变动声明-董事 Rodgers Richard J
美股SEC公告 ·  06/14 16:11
Moomoo AI 已提取核心信息
On June 12, 2024, Richard J Rodgers, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost, as per the exercise or conversion of a derivative security. Following this transaction, Rodgers directly holds a total of 10,470 shares of Novavax common stock. The transaction, which was carried out under the transaction code 'M', indicates a direct ownership type and has been completed successfully.
On June 12, 2024, Richard J Rodgers, associated with Novavax Inc [NVAX], completed a transaction to acquire 6,670 shares of the company's common stock at no cost, as per the exercise or conversion of a derivative security. Following this transaction, Rodgers directly holds a total of 10,470 shares of Novavax common stock. The transaction, which was carried out under the transaction code 'M', indicates a direct ownership type and has been completed successfully.
2024年6月12日,与诺瓦瓦克斯医药[NVAX]有关的理查德·J·罗杰斯完成了一笔交易,以零成本获取了6,670股公司普通股,因为这是衍生证券的行权或兑换。在此次交易后,罗杰斯直接持有诺瓦瓦克斯医药普通股共10,470股。该交易是在交易代码“M”下进行的,表明是直接所有权类型,且已成功完成。
2024年6月12日,与诺瓦瓦克斯医药[NVAX]有关的理查德·J·罗杰斯完成了一笔交易,以零成本获取了6,670股公司普通股,因为这是衍生证券的行权或兑换。在此次交易后,罗杰斯直接持有诺瓦瓦克斯医药普通股共10,470股。该交易是在交易代码“M”下进行的,表明是直接所有权类型,且已成功完成。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息